Showing 1 - 4 results of 4 for search 'Robert C. Carlisle', query time: 0.02s Refine Results
  1. 1
    Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery technologies

    Development and validation of the Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT), a scale for assessing public attitudes to next-generation vaccine delivery techno... by Jonathan Kantor, Robert C. Carlisle, Samantha Vanderslott, Andrew J. Pollard, Michael Morrison

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy

    Oxford Vaccine Hesitancy Scale (OVHS): a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess vaccine hesitancy by Samantha Vanderslott, Andrew J Pollard, Michael Morrison, Jonathan Kantor, Robert C Carlisle

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitudes and expectations in the general public

    The Oxford Needle Experience (ONE) scale: a UK-based and US-based online mixed-methods psychometric development and validation study of an instrument to assess needle fear, attitud... by Samantha Vanderslott, Andrew J Pollard, Michael Morrison, Jonathan Kantor, Robert C Carlisle

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation.

    A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation. by Thomas Hills, Phillip G Jakeman, Robert C Carlisle, Paul Klenerman, Leonard W Seymour, Ryan Cawood

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: